Vicarious Surgical (RBOT) Research & Development (2020 - 2025)

Vicarious Surgical (RBOT) has 6 years of Research & Development data on file, last reported at $8.0 million in Q3 2025.

• On a quarterly basis, Research & Development fell 25.99% year-over-year to $8.0 million in Q3 2025; TTM through Sep 2025 was $18.7 million, a 38.44% decrease from a year earlier, with the FY2024 full-year figure at $4.5 million, down 90.49% from the prior year.
• Research & Development for Q3 2025 stood at $8.0 million, up from $349000.0 in the prior quarter.
• Over the last five years, Research & Development for RBOT reached as high as $13.4 million in Q1 2023 and fell as low as $349000.0 in Q2 2025.
• Historically, Research & Development has averaged $4.8 million across 5 years, with a median of $1.9 million in 2022.
• Across the five-year window, Research & Development jumped 852.64% in 2023 and tumbled 88.44% in 2024, its largest moves.
• Year by year, Research & Development stood at $1.6 million in 2021, then gained by 17.22% to $1.8 million in 2022, then soared by 360.72% to $8.5 million in 2023, then tumbled by 88.44% to $979000.0 in 2024, then soared by 716.45% to $8.0 million in 2025.
• Per Business Quant data, the three most recent Research & Development figures were $8.0 million in Q3 2025, $349000.0 in Q2 2025, and $9.4 million in Q1 2025.